SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-197825
Filing Date
2020-07-23
Accepted
2020-07-23 16:36:29
Documents
2
Group Members
SHANGHAI PHARMACEUTICAL (USA) INC.SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d58507dsc13da.htm SC 13D/A 86802
2 EX-99.5 d58507dex995.htm EX-99.5 5038
  Complete submission text file 0001193125-20-197825.txt   93665
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Subject) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79588 | Film No.: 201044001
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCTERNAL THERAPEUTICS, INC. 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address C/O ONCTERNAL THERAPEUTICS, INC. 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 ((858) 434-1113
Shanghai Pharmaceuticals (HK) Investment Ltd (Filed by) CIK: 0001810280 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A